Rockefeller Capital Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
Rockefeller Capital Management's IART Position: Q3 2026 in Review
Rockefeller Capital Management increased its Integra LifeSciences (IART) stake by 529% in Q3 2026, buying an estimated $68.6K and bringing the position to 4,727 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #3217.
Rockefeller Capital Management first reported a position in IART in Q1 2019 and has held it in 12 quarters since. 179 funds tracked by Wall St. Rank hold IART as of Q3 2026.
- Rockefeller Capital Management held 4,727 shares of Integra LifeSciences worth $77K as of Q3 2026.
- Rockefeller Capital Management bought 3,976 Integra LifeSciences shares in Q3 2026, an estimated $68.6K.
- Integra LifeSciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3217 holding.
- Rockefeller Capital Management first reported a position in Integra LifeSciences in Q1 2019 and has held it in 12 quarters since.
- 179 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.